Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Shunt Tube Exposure Prevention Study [NA]
A completed clinical trial evaluating shunt tube exposure prevention in glaucoma patients; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: The Effects of the Water Drinking Test on Intraocular Pressure [NA]
A completed clinical trial evaluating the effects of the water drinking test on intraocular pressure in glaucoma patients with results poste…
-
FDA approval · 2019-08-13FDA Approved: PILOCARPINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for pilocarpine hydrochloride from Aurobindo Pharma Limited (ANDA 212377).
-
FDA approval · 2019-08-09FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc.'s original application for Dorzolamide Hydrochloride as a generic drug. It is used to lower intrao…
-
FDA approval · 2019-08-05FDA Approved: OSMITROL — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for Osmitol (mannitol) from Baxter Healthcare Company, indicating an update to its labeling/indicati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Interest in Electronic Applications for Patients With Glaucoma
A completed clinical trial update focusing on electronic applications for patients with glaucoma; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Vision Restoration Training in Glaucoma [Phase 2]
Phase 2 clinical trial investigating vision restoration training in glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure [Phase 2]
Phase 2 trial assessing daily oral CF101 for safety and efficacy in subjects with elevated intraocular pressure; study completed with result…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma [Phase 4]
A Phase 4 trial evaluating the impact of inhaled corticosteroids on intraocular pressure in patients with controlled glaucoma, with complete…
-
FDA approval · 2019-05-02FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings' original ANDA for timolol maleate, a generic ophthalmic beta-blocker intended to reduce intraocular pre…
-
CLINICAL_TRIALS research · 2019-04-19Clinical Trial Update: Pars Plana Ex-Press Shunt in Vitrectomized Eyes [Phase 1, Phase 2]
A clinical trial update for Pars Plana Ex-Press Shunt in vitrectomized eyes evaluating safety and efficacy in glaucoma patients, currently i…
-
FDA approval · 2019-04-12FDA Approved: BIMATOPROST — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for bimatoprost from Alembic Pharmaceuticals Inc., authorizing a generic version of the glaucoma medic…
-
FDA approval · 2019-03-11FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic Brimonidine tartrate ophthalmic product (Original Application) from Somerset Therapeutics, LLC to treat open-angle gl…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye [NA]
A completed clinical trial analyzing the eye in patients with primary open-angle glaucoma and a visual field defect in one eye; results post…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma [Phase 4]
A Phase 4 trial evaluated the additive effect of twice-daily brinzolamide/brimonidine combination as adjunctive therapy to travoprost in nor…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center [NA]
A completed clinical trial at Boston Medical Center evaluated whether Glaucoma Drop Aids improve medication adherence in glaucoma patients; …
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients? [NA]
Completed clinical trial evaluating whether a low vision aid device improves quality of life in glaucoma patients; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Does Glaucoma Cause Loss of Brain Function? [NA]
A completed clinical trial investigating whether glaucoma is associated with loss of brain function; results posted in 2018.
-
FDA approval · 2018-11-15FDA Approved: OSMITROL — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for Osmitrol (mannitol) submitted by Baxter Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: How Accurately Does the Diopsys Visual Evoked Potential (VEP) Vision Testing System Detect Glaucoma? [NA]
Clinical trial evaluating how accurately the Diopsys Visual Evoked Potential (VEP) testing system detects glaucoma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Spaeth/Richman Contrast Sensitivity Test [NA]
Clinical trial update for the Spaeth/Richman Contrast Sensitivity Test in glaucoma, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Long-Term Non-Interventional Latanoprost Study
Long-term non-interventional trial of latanoprost completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) [Phase 4]
A Phase 4 trial comparing Combigan BID to Simbrinza TID in glaucoma and ocular hypertension; results posted in 2018.
-
FDA approval · 2018-10-05FDA Approved: METHAZOLAMIDE — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's generic methazolamide (ANDA 207438) for the treatment of glaucoma.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Effect of Topical Dexmedetomidine on Intraocular Pressure [Phase 4]
Phase 4 trial update evaluating topical dexmedetomidine for reducing intraocular pressure in glaucoma patients has completed.